Pharma Services

  Robert is an experienced executive with over 30 years of leadership within the healthcare and laboratory industry. He has held various executive leadership positions over his decorated career, most recently as the Executive Vice President of Operations at Pathonostics. Prior to that role, Robert was the Vice President of Operations for Plus Diagnostics.  He has successfully started several companies, leading them through growth and acquisition stages.  Robert is a licensed histotechnologist (HT17899) and holds a Qualification in Immunohistochemistry (QIHC) from the American Society for Clinical Pathology (ASCP).  

 Jason has a strong track record of building and growing businesses during a distinguished career spanning nearly 25 years in healthcare. He has led healthcare service companies ranging in size from $35 million to $500 million in revenue. Prior to launching EmeritusDX, Jason was the Vice President of Operations for NeoGenomics, the nation's largest oncology reference laboratory. Prior to that he held several executive roles as Vice President of Operations for LabCorp’s Integrated Oncology and Dianon Divisions and later as Vice President of Operations for Pathnostics. Jason also founded Morningstar Laboratories, a pharma services company that was sold to a private equity group.  Jason received his bachelor’s of science degree in Economics from the Ohio State University and his MBA from the University of La Verne.  

 Dr. Funari's impressive 20-year career has centered on integrating genomic technologies into precision medicine, particularly concerning hematologic and solid tumors. He is licensed as a Clinical Genetic Molecular Biologist Scientist (CGMBS) by the California Department of Health Care Services.   

Previously, Dr. Funari held the position of Chief Scientific Officer at Imagia Canexia Health, where he spearheaded the development of pioneering tumor profiling laboratory developed tests (LDTs) for both clinical and commercial use. Before this role, he contributed significantly as the Chief Scientific Officer at NeoGenomics, overseeing the successful launch of several comprehensive genomic panels(CGP). Additionally, he transformed existing PCR products into commercially vital panels that elevated patient care. Finally in his 10 years at Cedars Sinai and UCLA as an associate professor, he co-authored over 35 peer reviewed publications in industry leading journals(eg NEJM, Science, Nature Genetics, Nature Immunology, Cell host and Microbe,etc) with over 5500 citations. He also helped to usher genomics and bioinformatics into precession medicine as a principal educator in Grand rounds and fellowship programs.

 Prior to starting Sprint Diagnostics Laboratory, Dr. Badir was in active pathology practice for over 26 years, including daily patient care and multiple laboratory directorships.  This included Medical Director of Empire Pathology Medical Group (1992 - 2003), Riverside Medical Clinic (1992 - present), Quest Diagnostics, FNA Clinics of America, US Labs, PLUS Diagnostics, LabCorp, Element 7 and Pathnostics laboratory.  Dr. Badir is currently the Laboratory Director of Pathnostics and Sprint Diagnostics. 
Dr. Badir is a graduate of Alexandria University School of Medicine, Egypt.  He received his residency training in Anatomic and Clinical Pathology at Kettering Medical Center in Dayton, Ohio, where he served as Chief Resident.  He received Fellowship training in Surgical Pathology and Fine Needle Aspiration Biopsy at the University of Texas South Western Medical Center at Dallas (Parkland Memorial Hospital).  Dr. Badir is board certified in Anatomic Pathology and Clinical Pathology.